- IBDEI225 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,32843,1,4,0)
- ;;=4^H40.31X4
- ;;^UTILITY(U,$J,358.3,32843,2)
- ;;=^5005855
- ;;^UTILITY(U,$J,358.3,32844,0)
- ;;=H40.32X0^^128^1670^7
- ;;^UTILITY(U,$J,358.3,32844,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32844,1,3,0)
- ;;=3^Traumatic GLC,OS,Stage Unspec
- ;;^UTILITY(U,$J,358.3,32844,1,4,0)
- ;;=4^H40.32X0
- ;;^UTILITY(U,$J,358.3,32844,2)
- ;;=^5005856
- ;;^UTILITY(U,$J,358.3,32845,0)
- ;;=H40.32X1^^128^1670^8
- ;;^UTILITY(U,$J,358.3,32845,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32845,1,3,0)
- ;;=3^Traumatic GLC,OS,Mild Stage
- ;;^UTILITY(U,$J,358.3,32845,1,4,0)
- ;;=4^H40.32X1
- ;;^UTILITY(U,$J,358.3,32845,2)
- ;;=^5005857
- ;;^UTILITY(U,$J,358.3,32846,0)
- ;;=H40.32X2^^128^1670^9
- ;;^UTILITY(U,$J,358.3,32846,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32846,1,3,0)
- ;;=3^Traumatic GLC,OS,Moderate Stage
- ;;^UTILITY(U,$J,358.3,32846,1,4,0)
- ;;=4^H40.32X2
- ;;^UTILITY(U,$J,358.3,32846,2)
- ;;=^5005858
- ;;^UTILITY(U,$J,358.3,32847,0)
- ;;=H40.32X3^^128^1670^10
- ;;^UTILITY(U,$J,358.3,32847,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32847,1,3,0)
- ;;=3^Traumatic GLC,OS,Severe Stage
- ;;^UTILITY(U,$J,358.3,32847,1,4,0)
- ;;=4^H40.32X3
- ;;^UTILITY(U,$J,358.3,32847,2)
- ;;=^5133504
- ;;^UTILITY(U,$J,358.3,32848,0)
- ;;=H40.32X4^^128^1670^11
- ;;^UTILITY(U,$J,358.3,32848,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32848,1,3,0)
- ;;=3^Traumatic GLC,OS,Indeterminate Stage
- ;;^UTILITY(U,$J,358.3,32848,1,4,0)
- ;;=4^H40.32X4
- ;;^UTILITY(U,$J,358.3,32848,2)
- ;;=^5005859
- ;;^UTILITY(U,$J,358.3,32849,0)
- ;;=H35.3230^^128^1671^25
- ;;^UTILITY(U,$J,358.3,32849,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32849,1,3,0)
- ;;=3^Exud AMD,OU,Stage Unspec
- ;;^UTILITY(U,$J,358.3,32849,1,4,0)
- ;;=4^H35.3230
- ;;^UTILITY(U,$J,358.3,32849,2)
- ;;=^5138528
- ;;^UTILITY(U,$J,358.3,32850,0)
- ;;=H35.3231^^128^1671^26
- ;;^UTILITY(U,$J,358.3,32850,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32850,1,3,0)
- ;;=3^Exud AMD,OU w/ Activ Chrdl Neovas
- ;;^UTILITY(U,$J,358.3,32850,1,4,0)
- ;;=4^H35.3231
- ;;^UTILITY(U,$J,358.3,32850,2)
- ;;=^5138529
- ;;^UTILITY(U,$J,358.3,32851,0)
- ;;=H35.3232^^128^1671^27
- ;;^UTILITY(U,$J,358.3,32851,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32851,1,3,0)
- ;;=3^Exud AMD,OU w/ Inact Chrdl Neovas
- ;;^UTILITY(U,$J,358.3,32851,1,4,0)
- ;;=4^H35.3232
- ;;^UTILITY(U,$J,358.3,32851,2)
- ;;=^5138530
- ;;^UTILITY(U,$J,358.3,32852,0)
- ;;=H35.3233^^128^1671^28
- ;;^UTILITY(U,$J,358.3,32852,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32852,1,3,0)
- ;;=3^Exud AMD,OU w/ Inactive Scar
- ;;^UTILITY(U,$J,358.3,32852,1,4,0)
- ;;=4^H35.3233
- ;;^UTILITY(U,$J,358.3,32852,2)
- ;;=^5138531
- ;;^UTILITY(U,$J,358.3,32853,0)
- ;;=H35.3220^^128^1671^21
- ;;^UTILITY(U,$J,358.3,32853,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32853,1,3,0)
- ;;=3^Exud AMD,OS,Stage Unspec
- ;;^UTILITY(U,$J,358.3,32853,1,4,0)
- ;;=4^H35.3220
- ;;^UTILITY(U,$J,358.3,32853,2)
- ;;=^5138524
- ;;^UTILITY(U,$J,358.3,32854,0)
- ;;=H35.3221^^128^1671^22
- ;;^UTILITY(U,$J,358.3,32854,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32854,1,3,0)
- ;;=3^Exud AMD,OS w/ Actv Chrdl Neovas
- ;;^UTILITY(U,$J,358.3,32854,1,4,0)
- ;;=4^H35.3221
- ;;^UTILITY(U,$J,358.3,32854,2)
- ;;=^5138525
- ;;^UTILITY(U,$J,358.3,32855,0)
- ;;=H35.3222^^128^1671^23
- ;;^UTILITY(U,$J,358.3,32855,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32855,1,3,0)
- ;;=3^Exud AMD,OS w/ Inact Chrdl Neovas
- ;;^UTILITY(U,$J,358.3,32855,1,4,0)
- ;;=4^H35.3222
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI225 3773 printed Jan 18, 2025@03:21:30 Page 2
- IBDEI225 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,32843,1,4,0)
- +2 ;;=4^H40.31X4
- +3 ;;^UTILITY(U,$J,358.3,32843,2)
- +4 ;;=^5005855
- +5 ;;^UTILITY(U,$J,358.3,32844,0)
- +6 ;;=H40.32X0^^128^1670^7
- +7 ;;^UTILITY(U,$J,358.3,32844,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,32844,1,3,0)
- +10 ;;=3^Traumatic GLC,OS,Stage Unspec
- +11 ;;^UTILITY(U,$J,358.3,32844,1,4,0)
- +12 ;;=4^H40.32X0
- +13 ;;^UTILITY(U,$J,358.3,32844,2)
- +14 ;;=^5005856
- +15 ;;^UTILITY(U,$J,358.3,32845,0)
- +16 ;;=H40.32X1^^128^1670^8
- +17 ;;^UTILITY(U,$J,358.3,32845,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,32845,1,3,0)
- +20 ;;=3^Traumatic GLC,OS,Mild Stage
- +21 ;;^UTILITY(U,$J,358.3,32845,1,4,0)
- +22 ;;=4^H40.32X1
- +23 ;;^UTILITY(U,$J,358.3,32845,2)
- +24 ;;=^5005857
- +25 ;;^UTILITY(U,$J,358.3,32846,0)
- +26 ;;=H40.32X2^^128^1670^9
- +27 ;;^UTILITY(U,$J,358.3,32846,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,32846,1,3,0)
- +30 ;;=3^Traumatic GLC,OS,Moderate Stage
- +31 ;;^UTILITY(U,$J,358.3,32846,1,4,0)
- +32 ;;=4^H40.32X2
- +33 ;;^UTILITY(U,$J,358.3,32846,2)
- +34 ;;=^5005858
- +35 ;;^UTILITY(U,$J,358.3,32847,0)
- +36 ;;=H40.32X3^^128^1670^10
- +37 ;;^UTILITY(U,$J,358.3,32847,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,32847,1,3,0)
- +40 ;;=3^Traumatic GLC,OS,Severe Stage
- +41 ;;^UTILITY(U,$J,358.3,32847,1,4,0)
- +42 ;;=4^H40.32X3
- +43 ;;^UTILITY(U,$J,358.3,32847,2)
- +44 ;;=^5133504
- +45 ;;^UTILITY(U,$J,358.3,32848,0)
- +46 ;;=H40.32X4^^128^1670^11
- +47 ;;^UTILITY(U,$J,358.3,32848,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,32848,1,3,0)
- +50 ;;=3^Traumatic GLC,OS,Indeterminate Stage
- +51 ;;^UTILITY(U,$J,358.3,32848,1,4,0)
- +52 ;;=4^H40.32X4
- +53 ;;^UTILITY(U,$J,358.3,32848,2)
- +54 ;;=^5005859
- +55 ;;^UTILITY(U,$J,358.3,32849,0)
- +56 ;;=H35.3230^^128^1671^25
- +57 ;;^UTILITY(U,$J,358.3,32849,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,32849,1,3,0)
- +60 ;;=3^Exud AMD,OU,Stage Unspec
- +61 ;;^UTILITY(U,$J,358.3,32849,1,4,0)
- +62 ;;=4^H35.3230
- +63 ;;^UTILITY(U,$J,358.3,32849,2)
- +64 ;;=^5138528
- +65 ;;^UTILITY(U,$J,358.3,32850,0)
- +66 ;;=H35.3231^^128^1671^26
- +67 ;;^UTILITY(U,$J,358.3,32850,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,32850,1,3,0)
- +70 ;;=3^Exud AMD,OU w/ Activ Chrdl Neovas
- +71 ;;^UTILITY(U,$J,358.3,32850,1,4,0)
- +72 ;;=4^H35.3231
- +73 ;;^UTILITY(U,$J,358.3,32850,2)
- +74 ;;=^5138529
- +75 ;;^UTILITY(U,$J,358.3,32851,0)
- +76 ;;=H35.3232^^128^1671^27
- +77 ;;^UTILITY(U,$J,358.3,32851,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,32851,1,3,0)
- +80 ;;=3^Exud AMD,OU w/ Inact Chrdl Neovas
- +81 ;;^UTILITY(U,$J,358.3,32851,1,4,0)
- +82 ;;=4^H35.3232
- +83 ;;^UTILITY(U,$J,358.3,32851,2)
- +84 ;;=^5138530
- +85 ;;^UTILITY(U,$J,358.3,32852,0)
- +86 ;;=H35.3233^^128^1671^28
- +87 ;;^UTILITY(U,$J,358.3,32852,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,32852,1,3,0)
- +90 ;;=3^Exud AMD,OU w/ Inactive Scar
- +91 ;;^UTILITY(U,$J,358.3,32852,1,4,0)
- +92 ;;=4^H35.3233
- +93 ;;^UTILITY(U,$J,358.3,32852,2)
- +94 ;;=^5138531
- +95 ;;^UTILITY(U,$J,358.3,32853,0)
- +96 ;;=H35.3220^^128^1671^21
- +97 ;;^UTILITY(U,$J,358.3,32853,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,32853,1,3,0)
- +100 ;;=3^Exud AMD,OS,Stage Unspec
- +101 ;;^UTILITY(U,$J,358.3,32853,1,4,0)
- +102 ;;=4^H35.3220
- +103 ;;^UTILITY(U,$J,358.3,32853,2)
- +104 ;;=^5138524
- +105 ;;^UTILITY(U,$J,358.3,32854,0)
- +106 ;;=H35.3221^^128^1671^22
- +107 ;;^UTILITY(U,$J,358.3,32854,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,32854,1,3,0)
- +110 ;;=3^Exud AMD,OS w/ Actv Chrdl Neovas
- +111 ;;^UTILITY(U,$J,358.3,32854,1,4,0)
- +112 ;;=4^H35.3221
- +113 ;;^UTILITY(U,$J,358.3,32854,2)
- +114 ;;=^5138525
- +115 ;;^UTILITY(U,$J,358.3,32855,0)
- +116 ;;=H35.3222^^128^1671^23
- +117 ;;^UTILITY(U,$J,358.3,32855,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,32855,1,3,0)
- +120 ;;=3^Exud AMD,OS w/ Inact Chrdl Neovas
- +121 ;;^UTILITY(U,$J,358.3,32855,1,4,0)
- +122 ;;=4^H35.3222